Uma Sinha

Uma Sinha, PhD has served as Eidos’ Chief Scientific Officer since June 2016 and as a member of its board of directors since December 2019. Dr. Sinha has served as the chief scientific officer at BridgeBio Pharma, LLC, since April 2016. Prior to that, Dr. Sinha served as chief scientific officer of Global Blood Therapeutics, Inc., from 2014 to 2015 and as senior vice president of research from 2013 to 2014. She was vice president, head of biology at Portola Pharmaceuticals, Inc., from 2010 to 2012 and was the vice president of translational biology from 2004 to 2010 and had held senior research positions at Millennium Pharmaceuticals, Inc., and COR Therapeutics, Inc. Dr. Sinha received her PhD in biochemistry from the University of Georgia and her B.Sc. with honors in chemistry from Presidency College.